Cargando…
It is time to end our love affair with short-acting β(2)-agonists in asthma? Yes
Why not directly eradicate SABA from asthma management? The time to leave behind SABA in asthma management is now. We wasted enough time identifying the key issue in asthma morbidity and mortality. Please, eradicate SABA. https://bit.ly/3DU4mmo
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969308/ https://www.ncbi.nlm.nih.gov/pubmed/36861059 http://dx.doi.org/10.1183/23120541.00555-2022 |